Skip to main content

Clear Cut Magazine

India’s Biopharma Shakti: How Budget 2026 Is Rebuilding the Nation’s Pharmaceutical and Medical Education Backbone

India’s Biopharma Shakti under Budget 2026 invests Rs 10,000 crore to expand NIPERs, establish 1,000 clinical trial sites, boost biosimilars, and train 1.5 lakh caregivers, aiming to transform India into a global pharmaceutical innovation hub. India is making its most ambitious bet yet on becoming a global biopharma powerhouse. Finance Minister Nirmala Sitharaman, presenting the…

Read More

Viksit Bharat in a Warming World: What Budget 2026 Must Get Right

India’s climate and energy discourse has entered a more mature phase, marked by a shifting intent from binding targets to inculcating a system readiness approach and embedding it into policy design. The outlining of India’s climate action strategies in the Economic Survey 2025-26 is notable because it repositions climate change as a structural economic variable…

Read More